Report Detail

Medical Devices & Consumables Global On-body Injectors Market Insights and Forecast to 2026

  • RnM4123197
  • |
  • 10 August, 2020
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

On-body Injectors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global On-body Injectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the On-body Injectors market is segmented into
Electronical Injectors
Mechanical Injectors
Others

Segment by Application, the On-body Injectors market is segmented into
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others

Regional and Country-level Analysis
The On-body Injectors market is analysed and market size information is provided by regions (countries).
The key regions covered in the On-body Injectors market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and On-body Injectors Market Share Analysis

On-body Injectors market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of On-body Injectors by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in On-body Injectors business, the date to enter into the On-body Injectors market, On-body Injectors product introduction, recent developments, etc.
The major vendors covered:
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen


1 Study Coverage

  • 1.1 On-body Injectors Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top On-body Injectors Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global On-body Injectors Market Size Growth Rate by Type
    • 1.4.2 Electronical Injectors
    • 1.4.3 Mechanical Injectors
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global On-body Injectors Market Size Growth Rate by Application
    • 1.5.2 Immuno-oncology
    • 1.5.3 Diabetes
    • 1.5.4 Cardiovascular Diseases
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global On-body Injectors Market Size, Estimates and Forecasts
    • 2.1.1 Global On-body Injectors Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global On-body Injectors Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global On-body Injectors Production Estimates and Forecasts 2015-2026
  • 2.2 Global On-body Injectors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global On-body Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global On-body Injectors Manufacturers Geographical Distribution
  • 2.4 Key Trends for On-body Injectors Markets & Products
  • 2.5 Primary Interviews with Key On-body Injectors Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top On-body Injectors Manufacturers by Production Capacity
    • 3.1.1 Global Top On-body Injectors Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top On-body Injectors Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top On-body Injectors Manufacturers Market Share by Production
  • 3.2 Global Top On-body Injectors Manufacturers by Revenue
    • 3.2.1 Global Top On-body Injectors Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top On-body Injectors Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by On-body Injectors Revenue in 2019
  • 3.3 Global On-body Injectors Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 On-body Injectors Production by Regions

  • 4.1 Global On-body Injectors Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top On-body Injectors Regions by Production (2015-2020)
    • 4.1.2 Global Top On-body Injectors Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America On-body Injectors Production (2015-2020)
    • 4.2.2 North America On-body Injectors Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America On-body Injectors Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe On-body Injectors Production (2015-2020)
    • 4.3.2 Europe On-body Injectors Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe On-body Injectors Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China On-body Injectors Production (2015-2020)
    • 4.4.2 China On-body Injectors Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China On-body Injectors Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan On-body Injectors Production (2015-2020)
    • 4.5.2 Japan On-body Injectors Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan On-body Injectors Import & Export (2015-2020)

5 On-body Injectors Consumption by Region

  • 5.1 Global Top On-body Injectors Regions by Consumption
    • 5.1.1 Global Top On-body Injectors Regions by Consumption (2015-2020)
    • 5.1.2 Global Top On-body Injectors Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America On-body Injectors Consumption by Application
    • 5.2.2 North America On-body Injectors Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe On-body Injectors Consumption by Application
    • 5.3.2 Europe On-body Injectors Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific On-body Injectors Consumption by Application
    • 5.4.2 Asia Pacific On-body Injectors Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America On-body Injectors Consumption by Application
    • 5.5.2 Central & South America On-body Injectors Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa On-body Injectors Consumption by Application
    • 5.6.2 Middle East and Africa On-body Injectors Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global On-body Injectors Market Size by Type (2015-2020)
    • 6.1.1 Global On-body Injectors Production by Type (2015-2020)
    • 6.1.2 Global On-body Injectors Revenue by Type (2015-2020)
    • 6.1.3 On-body Injectors Price by Type (2015-2020)
  • 6.2 Global On-body Injectors Market Forecast by Type (2021-2026)
    • 6.2.1 Global On-body Injectors Production Forecast by Type (2021-2026)
    • 6.2.2 Global On-body Injectors Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global On-body Injectors Price Forecast by Type (2021-2026)
  • 6.3 Global On-body Injectors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global On-body Injectors Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global On-body Injectors Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 BD Medical
    • 8.1.1 BD Medical Corporation Information
    • 8.1.2 BD Medical Overview
    • 8.1.3 BD Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 BD Medical Product Description
    • 8.1.5 BD Medical Related Developments
  • 8.2 Medtronic
    • 8.2.1 Medtronic Corporation Information
    • 8.2.2 Medtronic Overview
    • 8.2.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Medtronic Product Description
    • 8.2.5 Medtronic Related Developments
  • 8.3 Insulet
    • 8.3.1 Insulet Corporation Information
    • 8.3.2 Insulet Overview
    • 8.3.3 Insulet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Insulet Product Description
    • 8.3.5 Insulet Related Developments
  • 8.4 Sensile Medical
    • 8.4.1 Sensile Medical Corporation Information
    • 8.4.2 Sensile Medical Overview
    • 8.4.3 Sensile Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Sensile Medical Product Description
    • 8.4.5 Sensile Medical Related Developments
  • 8.5 Ypsomed
    • 8.5.1 Ypsomed Corporation Information
    • 8.5.2 Ypsomed Overview
    • 8.5.3 Ypsomed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Ypsomed Product Description
    • 8.5.5 Ypsomed Related Developments
  • 8.6 Enable Injections
    • 8.6.1 Enable Injections Corporation Information
    • 8.6.2 Enable Injections Overview
    • 8.6.3 Enable Injections Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Enable Injections Product Description
    • 8.6.5 Enable Injections Related Developments
  • 8.7 Roche
    • 8.7.1 Roche Corporation Information
    • 8.7.2 Roche Overview
    • 8.7.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Roche Product Description
    • 8.7.5 Roche Related Developments
  • 8.8 ScPharmaceuticals
    • 8.8.1 ScPharmaceuticals Corporation Information
    • 8.8.2 ScPharmaceuticals Overview
    • 8.8.3 ScPharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 ScPharmaceuticals Product Description
    • 8.8.5 ScPharmaceuticals Related Developments
  • 8.9 SteadyMed
    • 8.9.1 SteadyMed Corporation Information
    • 8.9.2 SteadyMed Overview
    • 8.9.3 SteadyMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 SteadyMed Product Description
    • 8.9.5 SteadyMed Related Developments
  • 8.10 CeQur
    • 8.10.1 CeQur Corporation Information
    • 8.10.2 CeQur Overview
    • 8.10.3 CeQur Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 CeQur Product Description
    • 8.10.5 CeQur Related Developments
  • 8.11 Tandem Diabetes Care
    • 8.11.1 Tandem Diabetes Care Corporation Information
    • 8.11.2 Tandem Diabetes Care Overview
    • 8.11.3 Tandem Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Tandem Diabetes Care Product Description
    • 8.11.5 Tandem Diabetes Care Related Developments
  • 8.12 Valeritas
    • 8.12.1 Valeritas Corporation Information
    • 8.12.2 Valeritas Overview
    • 8.12.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Valeritas Product Description
    • 8.12.5 Valeritas Related Developments
  • 8.13 SteadyMed Therapeutics
    • 8.13.1 SteadyMed Therapeutics Corporation Information
    • 8.13.2 SteadyMed Therapeutics Overview
    • 8.13.3 SteadyMed Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 SteadyMed Therapeutics Product Description
    • 8.13.5 SteadyMed Therapeutics Related Developments
  • 8.14 Amgen
    • 8.14.1 Amgen Corporation Information
    • 8.14.2 Amgen Overview
    • 8.14.3 Amgen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 Amgen Product Description
    • 8.14.5 Amgen Related Developments

9 On-body Injectors Production Forecast by Regions

  • 9.1 Global Top On-body Injectors Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top On-body Injectors Regions Forecast by Production (2021-2026)
  • 9.3 Key On-body Injectors Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 On-body Injectors Consumption Forecast by Region

  • 10.1 Global On-body Injectors Consumption Forecast by Region (2021-2026)
  • 10.2 North America On-body Injectors Consumption Forecast by Region (2021-2026)
  • 10.3 Europe On-body Injectors Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific On-body Injectors Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America On-body Injectors Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa On-body Injectors Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 On-body Injectors Sales Channels
    • 11.2.2 On-body Injectors Distributors
  • 11.3 On-body Injectors Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 On-body Injectors Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 On-body Injectors Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global On-body Injectors Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on On-body Injectors. Industry analysis & Market Report on On-body Injectors is a syndicated market report, published as Global On-body Injectors Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of On-body Injectors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,924.90
    5,887.35
    7,849.80
    4,576.60
    6,864.90
    9,153.20
    771,701.00
    1,157,551.50
    1,543,402.00
    408,611.00
    612,916.50
    817,222.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report